Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Other Non-Current Liabilities (2022 - 2026)

Prokidney's (PROK) quarterly Other Non-Current Liabilities came in at $1.1 million in Q2 2026, up 18.94% year-over-year from $903000.0 in Q2 2025, and little changed quarter-over-quarter from $1.1 million in Q1 2026.

Analysis

Prokidney (PROK) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends

Prokidney (PROK) has reported Other Non-Current Liabilities for 5 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 18.94% year-over-year to $1.1 million in Q2 2026; TTM through Jun 2026 was $1.1 million, a 18.94% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 43.58% from the prior year.
  • Other Non-Current Liabilities was $1.1 million for Q2 2026 at Prokidney, roughly flat from $1.1 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $1.1 million in Q4 2025 and troughed at $278000.0 in Q4 2022.
  • A 5-year average of $694000.0 and a median of $658000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
  • Across the five-year window, Other Non-Current Liabilities surged 104.32% in 2023 and rose 14.98% in 2024, its largest moves.
  • Over 5 years, Other Non-Current Liabilities stood at $278000.0 in 2022, then jumped by 104.32% to $568000.0 in 2023, then soared by 31.69% to $748000.0 in 2024, then surged by 43.58% to $1.1 million in 2025, then changed by 0.0% to $1.1 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $1.1 million (Q2 2026), $1.1 million (Q1 2026), and $1.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 Prokidney 346.07 Mn 346.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.07 Mn
Mar 31, 2026 1.07 Mn
Dec 31, 2025 1.07 Mn
Sep 30, 2025 962,000.00
Jun 30, 2025 903,000.00
Mar 31, 2025 764,000.00
Dec 31, 2024 748,000.00
Sep 30, 2024 772,000.00
Jun 30, 2024 568,000.00
Mar 31, 2024 568,000.00
Dec 31, 2023 568,000.00
Sep 30, 2023 522,000.00
Jun 30, 2023 494,000.00
Mar 31, 2023 426,000.00
Dec 31, 2022 278,000.00
Sep 30, 2022 309,000.00